{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:37:30Z","timestamp":1756384650023,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:p>Gout affects around 1% of people in the UK, most aged over 45 years.1 The condition, which is five times more common in men than women, usually presents as a painful inflammatory monoarthritis, which can be diagnosed clinically and successfully treated with a high dose of an NSAID. Problems arise when the features are atypical or when high doses of an NSAID are inappropriate. Also, there is no robust evidence to guide when to start prophylactic therapy or what advice to give on lifestyle changes. Here we review current practice and offer advice on managing patients with this increasingly common condition, concentrating on approaches to be taken by the non-specialist.<\/jats:p>","DOI":"10.1136\/dtb.2004.42537","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T16:15:40Z","timestamp":1216397740000},"page":"37-40","source":"Crossref","is-referenced-by-count":2,"title":["Gout in primary care"],"prefix":"10.1136","volume":"42","member":"239","published-online":{"date-parts":[[2004,5,1]]},"reference":[{"key":"2025082722365029000_42.5.37.1","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0895-4356(94)00244-K","article-title":"The prevalence and prophylaxis of gout in England","volume":"48","author":"Harris","year":"1995","journal-title":"J Clin Epidemiol"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.2","DOI":"10.1016\/0895-4356(94)00244-K"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.3","DOI":"10.1016\/S0149-2918(03)80158-3"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.4","DOI":"10.1002\/art.1780200320"},{"key":"2025082722365029000_42.5.37.5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0749-0690(18)30103-4","article-title":"Crystal-associated arthritis","volume":"14","author":"Agudelo","year":"1998","journal-title":"Clin Geriatr Med"},{"key":"2025082722365029000_42.5.37.6","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1001\/jama.289.21.2857","article-title":"Gout","volume":"289","author":"Rott","year":"2003","journal-title":"JAMA"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.7","DOI":"10.1001\/jama.289.21.2857"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.8","DOI":"10.1016\/0002-9343(87)90441-4"},{"key":"2025082722365029000_42.5.37.9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/bmj.310.6978.521","article-title":"ABC of rheumatology: gout, hyperuricaemia, and crystal arthritis","volume":"310","author":"Snaith","year":"1995","journal-title":"BMJ"},{"key":"2025082722365029000_42.5.37.10","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis","volume":"324","author":"Schumacher","year":"2002","journal-title":"BMJ"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.11","DOI":"10.1136\/bmj.324.7352.1488"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.12","DOI":"10.1002\/art.20007"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.13","DOI":"10.1111\/j.1445-5994.1987.tb01232.x"},{"unstructured":"Colchicine tablets BP 500mcg Summary of product characteristics, UK Celltech Manufacturing Services Ltd July 2001.","key":"2025082722365029000_42.5.37.14"},{"key":"2025082722365029000_42.5.37.15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0049-0172(90)90070-V","article-title":"Systemic steroid therapy for acute gout: a clinical trial and review of the literature","volume":"19","author":"Groff","year":"1990","journal-title":"Semin Arthritis Rheum"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.16","DOI":"10.1016\/0049-0172(90)90070-V"},{"key":"2025082722365029000_42.5.37.17","first-page":"2285","article-title":"Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide","volume":"26","author":"Fern\u00e1ndez","year":"1999","journal-title":"J Rheumatol"},{"key":"2025082722365029000_42.5.37.18","first-page":"331","article-title":"Local ice therapy during bouts of acute gouty arthritis","volume":"29","author":"Schlesinger","year":"2002","journal-title":"J Rheumatol"},{"key":"2025082722365029000_42.5.37.19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/ard.59.7.539","article-title":"Beneficial effects of weight loss associated with moderate calorie\/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study","volume":"59","author":"Dessin","year":"2000","journal-title":"Ann Rheum Dis"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.20","DOI":"10.1136\/ard.59.7.539"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.21","DOI":"10.1056\/NEJMoa035700"},{"doi-asserted-by":"publisher","key":"2025082722365029000_42.5.37.22","DOI":"10.1016\/S0140-6736(04)16000-5"},{"unstructured":"Zyloric tablets 100mg, 300mg Summary of product characteristics, UK The Wellcome Foundation Ltd UK June 2002.","key":"2025082722365029000_42.5.37.23"},{"unstructured":"Anturan tablets 100mg Summary of product characteristics, UK Novartis Pharmaceuticals UK Ltd July 2000.","key":"2025082722365029000_42.5.37.24"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2004.42537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:37:01Z","timestamp":1756359421000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2004.42537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2004,5,1]]},"published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1136\/dtb.2004.42537"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2004.42537","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}